INVESTOR RELATIONS

PRESS RELEASES

19-Dec-2007 AMARIN ANNOUNCES MANAGEMENT CHANGES INCLUDING APPOINTMENT OF NEW CEO
5-Dec-2007 AMARIN SIGNS AGREEMENT TO ACQUIRE ESTER NEUROSCIENCES
29-Nov-2007 AMARIN COMMENCES FIRST CLINICAL TRIAL IN CARDIOVASCULAR PROGRAM
20-Nov-2007 AMARIN REPORTS THIRD QUARTER 2007 FINANCIAL RESULTS
19-Nov-2007 AMARIN ANNOUNCES COMPLETION OF COMPREHENSIVE DATA ANALYSIS FROM PHASE III HUNTINGTONS DISEASE PROGRAM
15-Nov-2007 AMARIN ANNOUNCES THIRD QUARTER 2007 RESULTS CONFERENCE CALL
31-Oct-2007 AMARIN CORPORATION TO PRESENT AT ACUMEN BIOFIN RODMAN & RENSHAW NINTH ANNUAL HEALTHCARE CONFERENCE
10-Oct-2007 AMARIN ANNOUNCES INITIATION OF CARDIOVASCULAR DEVELOPMENT STRATEGY
9-Oct-2007 AMARIN TO PRESENT AT 4TH ANNUAL BIO INVESTOR FORUM
24-Sep-2007 AMARIN ANNOUNCES PUBLICATION OF PRE-CLINICAL MEMORY DATA IN JOURNAL OF NEUROCHEMISTRY
1-Aug-2007 AMARIN REPORTS SECOND QUARTER 2007 FINANCIAL RESULTS
27-Jul-2007 AMARIN ANNOUNCES SECOND QUARTER 2007 RESULTS CONFERENCE CALL
8-Jun-2007 AMARIN RECEIVES NASDAQ NOTIFICATION RELATED TO MINIMUM BID PRICE
4-Jun-2007 AMARIN ANNOUNCES COMPLETION OF EQUITY FINANCING
1-Jun-2007 AMARIN TO PRESENT AT FTN MIDWEST SECURITIES CORPORATION 2007 HEALTH CARE CONFERENCE
25-May-2007 AMARIN TO PRESENT AT BANK OF AMERICA 2007 HEALTH CARE CONFERENCE
11-May-2007 AMARIN CORPORATION TO PRESENT AT ACUMEN BIOFIN RODMAN & RENSHAW FOURTH ANNUAL GLOBAL HEALTHCARE CONFERENCE
10-May-2007 AMARIN REPORTS FIRST QUARTER 2007 RESULTS
4-May-2007 AMARIN ANNOUNCES FIRST QUARTER 2007 RESULTS CONFERENCE CALL
24-Apr-2007 AMARIN REPORTS TOP-LINE RESULTS OF TWO PHASE III STUDIES OF MIRAXION IN HUNTINGTON’S DISEASE
Page 1 of 2